98 related articles for article (PubMed ID: 22776555)
1. Expression and inhibition of ADAMDEC1 in craniopharyngioma cells.
Xu J; Liu L; Zheng X; You C; Li Q
Neurol Res; 2012 Sep; 34(7):701-6. PubMed ID: 22776555
[TBL] [Abstract][Full Text] [Related]
2. Craniopharyngioma cell growth is promoted by growth hormone (GH) and is inhibited by tamoxifen: involvement of growth hormone receptor (GHR) and IGF-1 receptor (IGF-1R).
Li Q; You C; Liu L; Rao Z; Sima X; Zhou L; Xu J
J Clin Neurosci; 2013 Jan; 20(1):153-7. PubMed ID: 23117141
[TBL] [Abstract][Full Text] [Related]
3. Clinical and prognostic role of annexin A2 in adamantinomatous craniopharyngioma.
Wang Y; Deng J; Guo G; Tong A; Peng X; Chen H; Xu J; Liu Y; You C; Zhou L
J Neurooncol; 2017 Jan; 131(1):21-29. PubMed ID: 27640198
[TBL] [Abstract][Full Text] [Related]
4. Expression and growth dependency of the insulin-like growth factor I receptor in craniopharyngioma cells: a novel therapeutic approach.
Ulfarsson E; Karström A; Yin S; Girnita A; Vasilcanu D; Thoren M; Kratz G; Hillman J; Axelson M; Larsson O; Girnita L
Clin Cancer Res; 2005 Jul; 11(13):4674-80. PubMed ID: 16000560
[TBL] [Abstract][Full Text] [Related]
5. Osteonectin expression in surrounding stroma of craniopharyngiomas: association with recurrence rate and brain infiltration.
Ebrahimi A; Honegger J; Schluesener H; Schittenhelm J
Int J Surg Pathol; 2013 Dec; 21(6):591-8. PubMed ID: 23648679
[TBL] [Abstract][Full Text] [Related]
6. [Expression of proliferating cell nuclear antigen in craniopharyngioma and tumor recurrence].
Pan J; Qi ST; Deng YJ; Ding YQ; Peng L; Li XQ
Di Yi Jun Yi Da Xue Xue Bao; 2002 Apr; 22(4):363-5. PubMed ID: 12390748
[TBL] [Abstract][Full Text] [Related]
7. Tight junction protein claudin-1 is differentially expressed in craniopharyngioma subtypes and indicates invasive tumor growth.
Stache C; Hölsken A; Fahlbusch R; Flitsch J; Schlaffer SM; Buchfelder M; Buslei R
Neuro Oncol; 2014 Jan; 16(2):256-64. PubMed ID: 24305709
[TBL] [Abstract][Full Text] [Related]
8. Craniopharyngiomas express embryonic stem cell markers (SOX2, OCT4, KLF4, and SOX9) as pituitary stem cells but do not coexpress RET/GFRA3 receptors.
Garcia-Lavandeira M; Saez C; Diaz-Rodriguez E; Perez-Romero S; Senra A; Dieguez C; Japon MA; Alvarez CV
J Clin Endocrinol Metab; 2012 Jan; 97(1):E80-7. PubMed ID: 22031517
[TBL] [Abstract][Full Text] [Related]
9. Does the calcification of adamantinomatous craniopharyngioma resemble the calcium deposition of osteogenesis/odontogenesis?
Song-Tao Q; Xiao-Rong Y; Jun P; Yong-Jian D; Jin L; Guang-Long H; Yun-Tao L; Jian R; Xiang-Zhao L; Jia-Ming X
Histopathology; 2014 Feb; 64(3):336-47. PubMed ID: 24387671
[TBL] [Abstract][Full Text] [Related]
10. High FABP5 Versus CRABPII Expression Ratio in Recurrent Craniopharyngiomas: Implications for Future Treatment.
Li Q; You C; Zhou L; Sima X; Liu Z; Liu H; Xu J
World Neurosurg; 2016 Oct; 94():197-205. PubMed ID: 27418530
[TBL] [Abstract][Full Text] [Related]
11. The ADAMDEC1 (decysin) gene structure: evolution by duplication in a metalloprotease gene cluster on chromosome 8p12.
Bates EE; Fridman WH; Mueller CG
Immunogenetics; 2002 May; 54(2):96-105. PubMed ID: 12037602
[TBL] [Abstract][Full Text] [Related]
12. Expression of aberrant beta-catenin and impaired p63 in craniopharyngiomas.
Cao J; Lin JP; Yang LX; Chen K; Huang ZS
Br J Neurosurg; 2010 Jun; 24(3):249-56. PubMed ID: 20128632
[TBL] [Abstract][Full Text] [Related]
13. [The establishment of craniopharyngioma cell line].
Xu JG; Liu L; Rao ZX; Zhou LX; Qiang L; Sima XT; Liu H; Liu ZY; You C
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 May; 42(3):417-21. PubMed ID: 21827012
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies targeting the disintegrin-like domain of ADAMDEC1 modulates the proteolytic activity and enables quantification of ADAMDEC1 protein in human plasma.
Lund J; Elimar Bitsch AM; Grønbech Rasch M; Enoksson M; Troeberg L; Nagase H; Loftager M; Overgaard MT; Petersen HH
MAbs; 2018 Jan; 10(1):118-128. PubMed ID: 29185848
[TBL] [Abstract][Full Text] [Related]
15. Aberrant membranous expression of β-catenin predicts poor prognosis in patients with craniopharyngioma.
Li Z; Xu J; Huang S; You C
Ann Diagn Pathol; 2015 Dec; 19(6):403-8. PubMed ID: 26547438
[TBL] [Abstract][Full Text] [Related]
16. Progesterone receptor gene expression in craniopharyngiomas and evidence for biological activity.
Honegger J; Renner C; Fahlbusch R; Adams EF
Neurosurgery; 1997 Dec; 41(6):1359-63; discussion 1363-4. PubMed ID: 9402587
[TBL] [Abstract][Full Text] [Related]
17. Expression of epithelial cell adhesion molecule and pituitary tumor transforming gene in adamantinomatous craniopharyngioma and its correlation with recurrence of the tumor.
Tena-Suck ML; Ortiz-Plata A; Galán F; Sánchez A
Ann Diagn Pathol; 2009 Apr; 13(2):82-8. PubMed ID: 19302955
[TBL] [Abstract][Full Text] [Related]
18. Hormone receptor expression in craniopharyngiomas: a clinicopathological correlation.
Hofmann BM; Hoelsken A; Fahlbusch R; Blümcke I; Buslei R
Neurosurgery; 2010 Sep; 67(3):617-25; discussion 625. PubMed ID: 20647974
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of craniopharyngiomas.
Kubo O; Tajika Y; Uchimuno H; Muragaki Y; Shimoda M; Hiyama H; Morishita K; Takakura K
Noshuyo Byori; 1993; 10(2):131-4. PubMed ID: 7693229
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis and cell proliferation in human craniopharyngioma xenografts in nude mice.
Xu J; You C; Zhang S; Huang S; Cai B; Wu Z; Li H
J Neurosurg; 2006 Oct; 105(4 Suppl):306-10. PubMed ID: 17328281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
